V

Veracyte
D

VCYT

39.540
USD
0.59
(1.51%)
Market Closed
Volume
64,217
EPS
1
Div Yield
-
P/E
-304
Market Cap
3,064,335,331
OverviewSignalsIdeasNews
Related Instruments
    NEOUSD
    NEOUSD
    1.011
    (8.64%)
    13.531054 USD
    C
    CDNA
    -0.400
    (-1.86%)
    21.160 USD
    E
    EXAS
    -1.680
    (-3.29%)
    49.330 USD
    F
    FGEN
    -0.03530
    (-9.54%)
    0.33460 USD
    G
    GH
    -1.065
    (-3.53%)
    29.130 USD
    I
    ILMN
    -7.180
    (-5.05%)
    135.110 USD
    N
    NEO
    -0.770
    (-4.87%)
    15.030 USD
    R
    RGEN
    -17.400
    (-12.22%)
    124.960 USD
    T
    TDOC
    0.23500
    (2.62%)
    9.19500 USD
    T
    TNDM
    -1.240
    (-4.34%)
    27.330 USD
    V
    VEEV
    -16.200
    (-7.06%)
    213.260 USD
    More
News

Title: Veracyte

Sector: Healthcare
Industry: Diagnostics & Research
Veracyte Inc is a genomic diagnostics company. It provides genomic diagnostic products and services to improve patient care against diseases such as thyroid cancer, lung cancer, and idiopathic pulmonary fibrosis. The firm's product portfolio consists of products such as Afirma analysis, Percepta, Envisia, and others.